Waqar M. Haque VIEW CLINICAL PROFILE

Waqar M. Haque, MD

Associate Professor of Clinical Radiation Oncology, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Biography

Dr. Haque is a native Houstonian and attended medical school at Baylor College of Medicine. He graduated in 2010 as a member of the Alpha Omega Alpha Medical Honor Society.  He completed residency in radiation oncology at the University of Texas Medical Branch in Galveston, during which he also spent time training at the MD Anderson Cancer Center.

Publications

Personalized Radiation Therapy for Breast Cancer
Haque, W, Butler, EB & Teh, BS 2024, , Current Oncology, vol. 31, no. 3, pp. 1588-1599. https://doi.org/10.3390/curroncol31030121

Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation
Riveros, C, Ranganathan, S, Haque, W, Huang, E, Xu, J, Kulkarni, GS, Geng, M, Anis, M, Muhammad, T, Chan, KS, Farach, A, Teh, BS, Miles, BJ, Klaassen, Z, Sonpavde, GP, Wallis, CJD & Satkunasivam, R 2024, , Journal of the Canadian Urological Association, vol. 18, no. 2, pp. 17-24. https://doi.org/10.5489/cuaj.8386

Personalized radiation therapy for glioblastoma
Haque, W, Brian Butler, E & Teh, BS 2024, , Chinese Clinical Oncology, vol. 13, no. 1, 11. https://doi.org/10.21037/cco-23-107

Radiation Pneumonitis, Really? A Case of Pulmonary Toxicity from CDK4/6 Inhibitor
Hunt, A, Haque, W, Pino, R, Farach, A, Butler, EB & Teh, BS 2023, , Anticancer Research, vol. 43, no. 8, pp. 3539-3542. https://doi.org/10.21873/anticanres.16531

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2023, , Clinical and Translational Radiation Oncology, vol. 39, 100592, pp. 100592. https://doi.org/10.1016/j.ctro.2023.100592

Neoadjuvant versus definitive chemoradiation in locally advanced esophageal cancer for patients of advanced age or significant comorbidities
Jensen, GL, Hammonds, KP & Haque, W 2023, , Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, vol. 36, no. 2. https://doi.org/10.1093/dote/doac050

De-escalation of Post-mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes
Halfteck, GG, Polychronopoulou, YE, Haque, W, Weiser, R, Hatch, SS & Klimberg, VS 2023, , Annals of Surgical Oncology, vol. 30, no. 13, pp. 8335-8343. https://doi.org/10.1245/s10434-023-14155-2

Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma
Chevli, N, Wang, K, Haque, W, Schwartz, MR, Nangia, J, Sasaki, J, Farach, AM, Hatch, SS, Butler, EB & Teh, BS 2022, , Clinical Breast Cancer, vol. 22, no. 7, pp. e807-e817. https://doi.org/10.1016/j.clbc.2022.06.005

21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age = 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy
Chevli, N, Haque, W, Tran, KT, Farach, AM, Schwartz, MR, Hatch, SS, Butler, EB & Teh, BS 2022, , Radiotherapy and Oncology, vol. 174, pp. 37-43. https://doi.org/10.1016/j.radonc.2022.06.013

Contemporary trends in management of uveal melanoma
Chevli, N, Zuhour, RJ, Messer, JA, Haque, W, Schefler, AC, Bernicker, EH, Chevez-Barrios, P, Farach, AM, Butler, EB & Teh, BS 2022, , Journal of Contemporary Brachytherapy, vol. 14, no. 2, pp. 123-129. https://doi.org/10.5114/jcb.2022.115210

Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma
Haque, W, Teh, C, Butler, EB & Teh, BS 2022, , Journal of Neuro-Oncology, vol. 157, no. 1, pp. 137-146. https://doi.org/10.1007/s11060-022-03955-3

Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis
Weiser, R, Polychronopoulou, E, Hatch, SS, Haque, W, Ghani, HA, He, J, Kuo, YF, Gradishar, WJ & Klimberg, VS 2022, , Cancer, vol. 128, no. 9, pp. 1738-1747. https://doi.org/10.1002/cncr.34127

Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes
Haque, W, Verma, V, Schwartz, MR, Lim, B, Mangalampalli, N, Butler, EB & Teh, BS 2022, , Clinical Breast Cancer, vol. 22, no. 5, pp. e691-e699. https://doi.org/10.1016/j.clbc.2022.01.006

Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer
Chevli, N, Haque, W, Tran, KT, Farach, AM, Schwartz, MR, Hatch, SS, Butler, EB & Teh, BS 2023, , Practical Radiation Oncology, vol. 13, no. 3, pp. e230-e238. https://doi.org/10.1016/j.prro.2022.08.004

Prognostic Effect of Systemic Therapy and Radiation Therapy in Stage I Nodal Marginal Zone Lymphoma
Chevli, N, Margolis, V, Haque, W, Pingali, SR, Butler, EB & Teh, BS 2023, , Practical Radiation Oncology, vol. 13, no. 1, pp. e80-e93. https://doi.org/10.1016/j.prro.2022.10.001

ASO Visual Abstract: Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases-An NCDB Analysis
Weiser, R, Polychronopoulou, E, Haque, W, Hatch, SS, He, J, Qiu, S, Markowitz, A, Gradishar, WJ, Kuo, YF & Klimberg, VS 2021, , Annals of Surgical Oncology, vol. 28, pp. 527-528. https://doi.org/10.1245/s10434-021-10419-x

Time Interval to Initiation of Whole-Brain Radiation Therapy in Patients With Small Cell Lung Cancer With Brain Metastasis
Chevli, N, Hunt, A, Haque, W, Farach, AM, Messer, JA, Sukpraprut-Braaten, S, Bernicker, EH, Zhang, J, Butler, EB & Teh, BS 2021, , Advances in Radiation Oncology, vol. 6, no. 6, 100783. https://doi.org/10.1016/j.adro.2021.100783

Prognostic Impact of Biologically Equivalent Dose in Stereotactic Body Radiation Therapy for Renal Cancer
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2021, , International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, pp. e262. https://doi.org/10.1016/j.ijrobp.2021.07.862

Postmastectomy Radiation Therapy Following Pathologic Complete Nodal Response to Neoadjuvant Chemotherapy
Haque, W, Verma, V, Teh, BS, Butler, EB, Hatch, SS, Desai, M, Arentz, SC, Jain, D, Schwartz, MR, Chevli, N & Farach, AM 2021, , International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, pp. e196. https://doi.org/10.1016/j.ijrobp.2021.07.707

21-Gene Recurrence Score Predictive for Patients Most Likely to Benefit From Postoperative Radiation Following Breast Conserving Surgery for T1N0 Breast Cancer
Chevli, NC, Haque, W, Tran, KT, Farach, AM, Schwartz, MR, Geyer, CE, Hatch, SS, Butler, EB & Teh, BS 2021, , International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, pp. e205. https://doi.org/10.1016/j.ijrobp.2021.07.728

VIEW FULL PUBLICATIONS